[{"AccountsPayableCurrent_0_Q2_USD":2429757.0,"OtherReceivablesNetCurrent_0_Q2_USD":3564317.0,"EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_2_Q2_pure":0.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":2977883.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":-7952998.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":21593656.0,"IncreaseDecreaseInOtherReceivables_2_Q2_USD":-2716511.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":2266738.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":1556548.0,"RepaymentsOfLongTermDebt_2_Q2_USD":0.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":2629635.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_0_Q2_USD":92480.0,"InvestmentIncomeInterest_2_Q2_USD":2264984.0,"InvestmentIncomeInterest_1_Q2_USD":965851.0,"InterestExpenseDebt_2_Q2_USD":32500.0,"InterestExpenseDebt_1_Q2_USD":16250.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-45409162.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-22959801.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":-198444.0,"OtherAssetsNoncurrent_0_Q2_USD":28777.0,"NonoperatingIncomeExpense_2_Q2_USD":2930236.0,"NonoperatingIncomeExpense_1_Q2_USD":1257344.0,"LongTermDebtNoncurrent_0_Q2_USD":2000000.0,"LongTermDebt_0_Q2_USD":2000000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":152477.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":697752.0,"MarketableSecuritiesCurrent_0_Q2_USD":221103306.0,"RevenueRemainingPerformanceObligation_0_Q2_USD":50500000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":-823694.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":7754959.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":41196165.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_2_Q2_USD":1556548.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q2_USD":2266738.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":2429500.0,"OperatingLeasePayments_2_Q2_USD":423096.0,"OperatingLeasePayments_1_Q2_USD":236272.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":1590758.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":920765.0,"OperatingLeaseLiability_0_Q2_USD":2511523.0,"OperatingLeaseCost_2_Q2_USD":469430.0,"OperatingLeaseCost_1_Q2_USD":262323.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":174470.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":307743.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":467005.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":1101185.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":2685993.0,"ContractWithCustomerLiabilityRevenueRecognized_2_Q2_USD":11364763.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":27489590.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":22964819.0,"ContractWithCustomerLiability_0_Q2_USD":50454409.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":12382599.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":221103306.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":219439182.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":7478.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":1671602.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":13874670.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":1117803.0,"AmortizationOfDebtDiscountPremium_2_Q2_USD":0.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":952850.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":15048202.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":3320609.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":3186093.0,"NetIncomeLoss_2_Q2_USD":-46965710.0,"NetIncomeLoss_1_Q2_USD":-25226539.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-38351947.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":48104911.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":2629635.0,"LiabilitiesCurrent_0_Q2_USD":33719801.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":262581573.0,"Liabilities_0_Q2_USD":64800149.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-404665.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":0.0,"ProfitLoss_2_Q2_USD":-46965710.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-2279547.0,"GeneralAndAdministrativeExpense_1_Q2_USD":8815474.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-1.22,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.65,"CommonStockValue_0_Q2_USD":38825.0,"CommonStockSharesOutstanding_0_Q2_shares":38825190.0,"CommonStockSharesIssued_0_Q2_shares":38825190.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":21593656.0,"AssetsCurrent_0_Q2_USD":249581888.0,"Assets_0_Q2_USD":262581573.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":5024646.0,"AdditionalPaidInCapital_0_Q2_USD":615601031.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":1664124.0,"GeneralAndAdministrativeExpense_2_Q2_USD":16740479.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":12000000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":10541408.0,"Revenues_1_Q2_USD":5747681.0,"EffectiveIncomeTaxRateContinuingOperations_2_Q2_pure":0.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q2_pure":0.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":4506794.0,"StockIssuedDuringPeriodValueStockOptionsExercised_2_Q2_USD":2629635.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":1279153.0,"ShareBasedCompensation_2_Q2_USD":13874670.0,"ResearchAndDevelopmentExpense_2_Q2_USD":45142776.0,"ResearchAndDevelopmentExpense_1_Q2_USD":23416090.0,"OperatingIncomeLoss_2_Q2_USD":-49895946.0,"OperatingIncomeLoss_1_Q2_USD":-26483883.0,"OperatingExpenses_2_Q2_USD":61883255.0,"OperatingExpenses_1_Q2_USD":32231564.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-419522556.0,"InterestPaidNet_2_Q2_USD":32500.0,"InterestExpense_1_Q2_USD":16250.0,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_2_Q2_pure":0.21,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1_Q2_pure":0.21,"DepreciationAndAmortization_2_Q2_USD":1252573.0,"DepreciationAndAmortization_1_Q2_USD":635104.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"CommitmentsAndContingencies_0_Q2_USD":null,"AccruedLiabilitiesCurrent_0_Q2_USD":7404460.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":38739922.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":38644209.0,"StockholdersEquity_0_Q2_USD":197781424.0,"Revenues_2_Q2_USD":11987309.0,"InterestExpense_2_Q2_USD":32500.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":546612.0,"Ticker":"ARVN","CIK":"1655759","name":"ARVINAS, INC.","OfficialName":"Arvinas Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"3525475441.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200804"}]